<code id='817A174B0B'></code><style id='817A174B0B'></style>
    • <acronym id='817A174B0B'></acronym>
      <center id='817A174B0B'><center id='817A174B0B'><tfoot id='817A174B0B'></tfoot></center><abbr id='817A174B0B'><dir id='817A174B0B'><tfoot id='817A174B0B'></tfoot><noframes id='817A174B0B'>

    • <optgroup id='817A174B0B'><strike id='817A174B0B'><sup id='817A174B0B'></sup></strike><code id='817A174B0B'></code></optgroup>
        1. <b id='817A174B0B'><label id='817A174B0B'><select id='817A174B0B'><dt id='817A174B0B'><span id='817A174B0B'></span></dt></select></label></b><u id='817A174B0B'></u>
          <i id='817A174B0B'><strike id='817A174B0B'><tt id='817A174B0B'><pre id='817A174B0B'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:17
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          What don’t we know about an Alzheimer’s drug side effect?
          What don’t we know about an Alzheimer’s drug side effect?

          Illustration:AlexHogan/STAT;Photo:EisaiviaAPSincetheFDA’sapprovaloflecanemab(marketedasLeqembi)andMe

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          BIO selects John Crowley as new CEO

          JohnCrowleypicturedwithhisdaughterMegan.CrowleyfamilyWASHINGTON— TheBiotechnologyInnovationOrganizat